Vaccination with the repeat β-hCG C-terminal peptide carried by heat shock protein-65 (HSP65) for inducing antitumor effects

Tumor Biology

Volumn 33, Issue 5, 2012, Pages 1777-1784

  Yang, Jie ^a,b   Zhang, Yankai ^a   Wang, Huaqian ^a,c   Gao, Zhenqiu ^a   Wang, Zeyu ^a   Liu, Bin ^a   Zhang, Xiuhua ^a   Du, Mingzhu ^a   Huang, Xiao ^a   Xu, Maolei ^a   Wu, Jie ^a   Li, Taiming ^a   Liu, Jingjing ^a   Cao, Rongyue ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b XUZHOU MEDICAL UNIVERSITY   (China)

^c GUANGDONG UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Heat shock protein 65; Human chorionic gonadotropin (hCG); Immunotherapy; Tandem repeats

Indexed keywords

CHORIONIC GONADOTROPIN ANTIBODY; CHORIONIC GONADOTROPIN BETA SUBUNIT; HEAT SHOCK PROTEIN 65;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CARBOXY TERMINAL SEQUENCE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFICACY; EHRLICH ASCITES TUMOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMORAL IMMUNITY; IMMUNOGENICITY; LYMPHOCYTE PROLIFERATION; MOUSE; MYCOBACTERIUM; NONHUMAN; PRIORITY JOURNAL; TANDEM REPEAT; WESTERN BLOTTING;

EID: 84868155269     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-012-0437-9     Document Type: Article

References (23)

1. Yi H, Rong Y, Yankai Z, Wentao L, Hongxia Z, Jie W, Rongyue C, Taiming L, Jingjing L. Improved efficacy of DNA vaccination against breast cancer by boosting with the repeat beta-hCG C-terminal peptide carried by mycobacterial heat-shock protein HSP65. Vaccine. 2006;24:2575-84.
2. Yankai Z, Rong Y, Yi H, Wentao L, Rongyue C, Ming Y, Taiming L, Jingjing L, Jie W. Ten tandem repeats of beta-hCG 109-118 enhance immunogenicity and anti-tumor effects of beta-hCG C-terminal peptide carried by mycobacterial heat-shock protein HSP65. Biochem Biophys Res Commun. 2006;345:1365-71.
3. Kofler R, Berger P, Wick G. Monoclonal antibodies against human chorionic gonadotropin (hCG): I. Production, specificity, and intramolecular binding sites. Am J Reprod Immunol. 1982;2:212-6.
4. Butler SA, Iles RK. The free monomeric beta subunit of human chorionic gonadotrophin (hCG beta) and the recently identified homodimeric beta-beta subunit (hCG beta beta) both have autocrine growth effects. Tumor Biology. 2004;25:18-23.
5. Stenman UH, Alfthan H, Hotakainen K. Human chorionic gonadotropin in cancer. Clin Biochem. 2004;37:549-61.
6. Xiangbing H, Yankai Z, Ming L, Yong L, Yu Z, Huiyong Z, Yingying C, Jing H, Yun X, Liang J, Rongyue C, Jingjing L. The fusion protein of HSP65 with tandem repeats of beta-hCG acting as a potent tumor vaccine in suppressing hepatocarcinoma. Int Immunopharmacol. 2010;10:230-8.
7. Sun Z, Yang J, Guo L. Ovarian non-small cell neuroendocrine carcinoma associated with increased HCG beta. J Clin Pathol. 2011;65(4):375-6.
8. Khattri S, Vivekanandarajah A, Varma S, Kong F. Secretion of beta-human chorionic gonadotropin by non-small cell lung cancer: a case report. J Med Case Reports. 2011;5:19.
9. Guo X, Liu G, Schauer IG, Yang G, Mercado-Uribe I, Yang F, Zhang S, He Y, Liu J. Overexpression of the beta subunit of human chorionic gonadotropin promotes the transformation of human ovarian epithelial cells and ovarian tumorigenesis. Am J Pathol. 2011;179:1385-93.
10. Boss DS, Glen H, Beijnen JH, de Jong D, Wanders J, Evans TR, Schellens JH. Serum beta-HCG and CA-125 as tumor markers in a patient with osteosarcoma: case report. Tumori. 2011;97:109-14.
11. Triozzi PL, Stevens VC. Human chorionic gonadotropin as a target for cancer vaccines. Oncol Rep. 1999;6:7-17.
12. Charrel-Dennis M, Jackson AM, Lund T, Lapthorn AJ, Berger P, Roitt IM, Delves PJ. The major hormone-specific discontinuous epitopes on human chorionic gonadotrophin. J Mol Endocrinol. 2004;32:571-81.
13. Delves PJ, Iles RK, Roitt IM, Lund T. Designing a new generation of anti-hCG vaccines for cancer therapy. Mol Cell Endocrinol. 2007;260-262:276-81.
14. Deshmukh US, Talwar GP, Gupta SK. Antibody response against three epitopic domains on human chorionic gonadotropin (hCG) in women and rodents immunized with a beta hCG-based immunocontraceptive vaccine. J Clin Immunol. 1994;14:162-8.
15. Bellet D, Bidart JM, Jolivet M, Tartar A, Caillaud JM, Ozturk M, Strugo MC, Audibert F, Gras-Masse H, Assicot M, et al. A monoclonal antibody against a synthetic peptide is specific for the free native human chorionic gonadotropin beta-subunit. Endocrinology. 1984;115:330-6.
16. Triozzi PL, Stevens VC, Aldrich W, Powell J, Todd CW, Newman MJ. Effects of a beta-human chorionic gonadotropin subunit immunogen administered in aqueous solution with a novel nonionic block copolymer adjuvant in patients with advanced cancer. Clin Cancer Res. 1997;3:2355-62.
17. Moulton HM, Yoshihara PH, Mason DH, Iversen PL, Triozzi PL. Active specific immunotherapy with a beta-human chorionic gonadotropin peptide vaccine in patients with metastatic colorectal cancer: antibody response is associated with improved survival. Clin Cancer Res. 2002;8:2044-51.
18. Hsu CT, Ting CY, Ting CJ, Chen TY, Lin CP, Whang-Peng J, Hwang J. Vaccination against gonadotropin-releasing hormone (GnRH) using toxin receptor-binding domain-conjugated GnRH repeats. Cancer Res. 2000;60:3701-5.
19. Xiangbing H, Yankai Z, Ming L, Yong L, Yu Z, Huiyong Z, Yingying C, Jing H, Yun X, Liang J. The fusion protein of HSP65 with tandem repeats of β-hCG acting as a potent tumor vaccine in suppressing hepatocarcinoma. Int Immunopharmacol. 2010;10:230-8.
20. He LZ, Ramakrishna V, Connolly JE, Wang XT, Smith PA, Jones CL, Valkova-Valchanova M, Arunakumari A, Treml JF, Goldstein J, Wallace PK, Keler T, Endres MJ. A novel human cancer vaccine elicits cellular responses to the tumor-associated antigen, human chorionic gonadotropin beta. Clin Cancer Res. 2004;10:1920-7.
21. Guojun W, Wei G, Kedong O, Yi H, Yanfei X, Qingmei C, Yankai Z, Jie W, Hao F, Taiming L, Jingjing L, Rongyue C. A novel vaccine targeting gastrin-releasing peptide: efficient inhibition of breast cancer growth in vivo. Endocr Relat Cancer. 2008;15:149-59.
22. Jinshu X, Jingjing L, Duan P, Zheng Z, Ding M, Jie W, Rongyue C, Zhuoyi H, Roque RS. A synthetic gonadotropin-releasing hormone (GnRH) vaccine for control of fertility and hormone dependent diseases without any adjuvant. Vaccine. 2005;23:4834-43.
23. Li D, Li H, Zhang P, Wu X, Wei H, Wang L, Wan M, Deng P, Zhang Y, Wang J, Liu Y, Yu Y, Wang L. Heat shock fusion protein induces both specific and nonspecific anti-tumor immunity. Eur J Immunol. 2006;36:1324-36.